<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5(12)</volume><submitter>Wisk LE</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>Long-term sequelae after symptomatic SARS-CoV-2 infection may impact well-being, yet existing data primarily focus on discrete symptoms and/or health care use.&lt;h4>Objective&lt;/h4>To compare patient-reported outcomes of physical, mental, and social well-being among adults with symptomatic illness who received a positive vs negative test result for SARS-CoV-2 infection.&lt;h4>Design, setting, and participants&lt;/h4>This cohort study was a planned interim analysis of an ongoing multicenter prospective longitudinal registry study (the Innovative Support for Patients With SARS-CoV-2 Infections Registry [INSPIRE]). Participants were enrolled from December 11, 2020, to September 10, 2021, and comprised adults (aged ≥18 years) with acute symptoms suggestive of SARS-CoV-2 infection at t</pubmed_abstract><journal>JAMA network open</journal><pagination>e2244486</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9716377</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Association of Initial SARS-CoV-2 Test Positivity With Patient-Reported Well-being 3 Months After a Symptomatic Illness.</pubmed_title><pmcid>PMC9716377</pmcid><pubmed_authors>Huebinger RM</pubmed_authors><pubmed_authors>Patel A</pubmed_authors><pubmed_authors>Koo K</pubmed_authors><pubmed_authors>Montoy JCC</pubmed_authors><pubmed_authors>Slovis BH</pubmed_authors><pubmed_authors>Chavez S</pubmed_authors><pubmed_authors>Lin Z</pubmed_authors><pubmed_authors>Kane A</pubmed_authors><pubmed_authors>Idris AH</pubmed_authors><pubmed_authors>Lyon V</pubmed_authors><pubmed_authors>Ruiz L</pubmed_authors><pubmed_authors>Sharma A</pubmed_authors><pubmed_authors>Chan V</pubmed_authors><pubmed_authors>Hunt A</pubmed_authors><pubmed_authors>Weinstein RA</pubmed_authors><pubmed_authors>Elmore JG</pubmed_authors><pubmed_authors>Ulrich A</pubmed_authors><pubmed_authors>Li SX</pubmed_authors><pubmed_authors>Plumb ID</pubmed_authors><pubmed_authors>Marella P</pubmed_authors><pubmed_authors>Diaz Roldan K</pubmed_authors><pubmed_authors>Nichol G</pubmed_authors><pubmed_authors>Eguchi M</pubmed_authors><pubmed_authors>Park J</pubmed_authors><pubmed_authors>Willis M</pubmed_authors><pubmed_authors>Hill MJ</pubmed_authors><pubmed_authors>Geyer RE</pubmed_authors><pubmed_authors>McDonald SA</pubmed_authors><pubmed_authors>Chalfin M</pubmed_authors><pubmed_authors>Fernandes A</pubmed_authors><pubmed_authors>Chavez CL</pubmed_authors><pubmed_authors>Hall AJ</pubmed_authors><pubmed_authors>Grau DT</pubmed_authors><pubmed_authors>Morse D</pubmed_authors><pubmed_authors>Villegas N</pubmed_authors><pubmed_authors>Shughart H</pubmed_authors><pubmed_authors>Gottlieb MA</pubmed_authors><pubmed_authors>Kemball R</pubmed_authors><pubmed_authors>Malone K</pubmed_authors><pubmed_authors>Chang AM</pubmed_authors><pubmed_authors>Yu H</pubmed_authors><pubmed_authors>Miao J</pubmed_authors><pubmed_authors>Wang RC</pubmed_authors><pubmed_authors>Morse S</pubmed_authors><pubmed_authors>Schaeffer KW</pubmed_authors><pubmed_authors>Chandler CW</pubmed_authors><pubmed_authors>Martin KR</pubmed_authors><pubmed_authors>Arab AI</pubmed_authors><pubmed_authors>Hannikainen P</pubmed_authors><pubmed_authors>Wong A</pubmed_authors><pubmed_authors>Spatz ES</pubmed_authors><pubmed_authors>Hota B</pubmed_authors><pubmed_authors>Briggs-Hagen M</pubmed_authors><pubmed_authors>Venkatesh AK</pubmed_authors><pubmed_authors>Stephens KA</pubmed_authors><pubmed_authors>Kelly M</pubmed_authors><pubmed_authors>O'Laughlin KN</pubmed_authors><pubmed_authors>Rodriguez R</pubmed_authors><pubmed_authors>Kinsman J</pubmed_authors><pubmed_authors>Cheng D</pubmed_authors><pubmed_authors>Watts PB</pubmed_authors><pubmed_authors>Black K</pubmed_authors><pubmed_authors>Stober T</pubmed_authors><pubmed_authors>Krumholz H</pubmed_authors><pubmed_authors>Dorney J</pubmed_authors><pubmed_authors>Adams K</pubmed_authors><pubmed_authors>L'Hommedieu M</pubmed_authors><pubmed_authors>Anderson J</pubmed_authors><pubmed_authors>Moreno R</pubmed_authors><pubmed_authors>Lin JS</pubmed_authors><pubmed_authors>Saydah S</pubmed_authors><pubmed_authors>Shutty C</pubmed_authors><pubmed_authors>Gallegos GD</pubmed_authors><pubmed_authors>Shughart LA</pubmed_authors><pubmed_authors>INSPIRE Group</pubmed_authors><pubmed_authors>Santangelo M</pubmed_authors><pubmed_authors>Wisk LE</pubmed_authors><pubmed_authors>Gentile NL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association of Initial SARS-CoV-2 Test Positivity With Patient-Reported Well-being 3 Months After a Symptomatic Illness.</name><description>&lt;h4>Importance&lt;/h4>Long-term sequelae after symptomatic SARS-CoV-2 infection may impact well-being, yet existing data primarily focus on discrete symptoms and/or health care use.&lt;h4>Objective&lt;/h4>To compare patient-reported outcomes of physical, mental, and social well-being among adults with symptomatic illness who received a positive vs negative test result for SARS-CoV-2 infection.&lt;h4>Design, setting, and participants&lt;/h4>This cohort study was a planned interim analysis of an ongoing multicenter prospective longitudinal registry study (the Innovative Support for Patients With SARS-CoV-2 Infections Registry [INSPIRE]). Participants were enrolled from December 11, 2020, to September 10, 2021, and comprised adults (aged ≥18 years) with acute symptoms suggestive of SARS-CoV-2 infection at t</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-21T23:23:04.32Z</modification><creation>2025-04-05T19:05:45.94Z</creation></dates><accession>S-EPMC9716377</accession><cross_references><pubmed>36454572</pubmed><doi>10.1001/jamanetworkopen.2022.44486</doi></cross_references></HashMap>